Drugs.com - Monthly Update July 2026

This July 2026 Drugs.com Monthly Update covers several new FDA approvals that provide novel treatment options and expand therapeutic possibilities.Gwyn Lo (ethinyl estradiol and norelgestromin): A new once-weekly transdermal patch providing low-dose estrogen and progestin for pregnancy prevention.Lytenava (bevacizumab-vikg): The first FDA-approved ophthalmic formulation of bevacizumab for patients with wet age-related macular degeneration.Simtriyo (centanafadine): A novel triple reuptake inhibitor approved for the treatment of ADHD in adults and pediatric patients 6 years and older.Jideytro (zidesamtinib): A brain-penetrant ROS1 inhibitor approved for adults with advanced ROS1-positive non-small cell lung cancer previously treated with a ROS1 inhibitor.Lipfendra (enlicitide): The first oral PCSK9 inhibitor approved to significantly reduce LDL-C in adults with hypercholesterolemia and heterozygous familial hypercholesterolemiaTylenol with naproxen: The first OTC combination of acetaminophen and naproxen.Chapters:(00:20) - Intro (01:14) - Gwyn Lo (02:18) - Lytenava (03:25) - Simtriyo (04:27) - Jideytro (05:33) - Lipfendra (06:20) - Tylenol with Naproxen (07:04) - Outro Follow Drugs.com:X, Facebook, YouTubeSign up to our newslettersDownload the app